行情

ICCC

ICCC

ImmuCell
NASDAQ

实时行情|Nasdaq Last Sale

4.190
+0.190
+4.75%
休市 16:00 04/09 EDT
开盘
4.040
昨收
4.000
最高
4.300
最低
4.010
成交量
9,597
成交额
--
52周最高
8.13
52周最低
3.700
市值
3,022.21万
市盈率(TTM)
-24.6906
分时
5日
1月
3月
1年
5年

ICCC 新闻

更多
  • The Daily Biotech Pulse: Sanofi, Regeneron Finalize Praluent Restructuring, Natus Pre-Announces Q1 Shortfall, Alcon To Delay Dividend Initiation
  • Benzinga · 2天前
  • The Daily Biotech Pulse: Fate Therapeutics Inks Cell Therapy Deal With J&J, Zentalis IPO
  • Benzinga · 6天前
  • The Daily Biotech Pulse: Fate Therapeutics Inks Cell Therapy Deal With J&J, Zentalis IPO
  • Benzinga · 04/03 11:36
  • ImmuCell Announces Preliminary, Unaudited Product Sales Results for the Quarter Ended March 31, 2020
  • GlobeNewswire · 04/02 21:29

所属板块

生物技术和医学研究
+1.60%
制药与医学研究
+0.82%

热门股票

代码
价格
涨跌幅

ICCC 简况

ImmuCell Corporation is an animal health company. The Company operates in the development, acquisition, manufacture and sale of products that improve the health and productivity of cows for the dairy and beef industries segment. The Company has developed products that provide immediate immunity to newborn dairy and beef cattle, and is developing product line extensions of its existing products that address mastitis. The Company's lead product, First Defense, is manufactured from cows' colostrum utilizing its vaccine and milk protein purification technologies. Its Wipe Out Dairy Wipes are made from a non-woven fabric that allows for a vigorous cleaning. It also developed California Mastitis Test (CMT), which is used for bulk tank, as well as individual cow sample monitoring and is used to determine which quarter of the udder is mastitic. Its product development initiative is Mast Out, a Nisin-based intramammary treatment of subclinical mastitis in lactating dairy cows.
展开

微牛提供ImmuCell Corporation(NASDAQ-ICCC)的股票价格,实时市场报价,专业分析师评级,深度图表和免费的ICCC股票新闻,以帮助您做出投资决策。